Literature DB >> 26331965

CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma.

W-M Li1, H-R Liu1,2.   

Abstract

Tumour immunity regulates tumour restriction to the site of occurrence. Failure of this balance facilitates tumour spread beyond the primary organ of origin. Tregs are known to be recruited in infections, including viral infections like hepatitis B and hepatitis C. Thus, they form a continuum of initial viral infection, an environment of immune suppression by recruitment of Tregs, intrinsic viral-mediated nuclear transformation and carcinogenesis, and thereafter worsening of progress, including metastasis due to the Tregs suppressing the cell-mediated destruction of tumour cells. In this study, we obtained advanced grades of hepatocellular carcinoma (HCC) and examined the cytokines that is potentially known to recruit Tregs. We examined the expression of CCL20, the cytokine that recruits Tregs. We isolated Tregs from HCC samples and examined expression of CCR6, the receptor for CCL20 and compared expression in control tissues obtained mainly from subjects with cirrhosis, but no evidence of cancer. The findings of this study indicate that mRNA expression of CCL20 is significantly enhanced, along with expression of mRNA for the cytokines IL17 and IL6. Furthermore, tissue expression of Gamma-interferon was reduced in HCC. When Tregs were isolated from the liver cancer samples, the expression of CCR6, the only and specific receptor for CCL20, was upregulated in the cancer tissue derived Tregs . Furthermore, STAT3 levels were significantly increased in these tumour-derived Tregs. This study demonstrates that immune evasion mechanisms are operant in hepatocellular carcinoma through a transcriptional network of CCL20-IL17-IL6 cytokines that facilitate immune suppression-mediated cancer cell elimination and metastasis.
© 2015 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26331965     DOI: 10.1111/sji.12367

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p.

Authors:  Amanda Hanson; Ignazio S Piras; Danielle Wilhelmsen; Christopher D Still; Xin Chu; Anthony Petrick; Glenn S Gerhard; Johanna K DiStefano
Journal:  Cytokine       Date:  2019-07-25       Impact factor: 3.861

Review 2.  Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response.

Authors:  Thorsten R Mempel; Francesco Marangoni
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

3.  The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.

Authors:  Xiaolei Jiao; Guiming Shu; Hui Liu; Qin Zhang; Zhe Ma; Chaoyi Ren; Hongsheng Guo; Jingxiang Shi; Junguo Liu; Chuanshan Zhang; Yijun Wang; Yingtang Gao
Journal:  J Histochem Cytochem       Date:  2019-01-11       Impact factor: 2.479

4.  DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma.

Authors:  Gaoda Ju; Tianhao Zhou; Rui Zhang; Xiaozao Pan; Bing Xue; Sen Miao
Journal:  PeerJ       Date:  2021-08-03       Impact factor: 2.984

5.  CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies.

Authors:  Dongrui Wang; Briana C Prager; Christine E Brown; Jeremy N Rich; Ryan C Gimple; Brenda Aguilar; Darya Alizadeh; Hongzhen Tang; Deguan Lv; Renate Starr; Alfonso Brito; Qiulian Wu; Leo J Y Kim; Zhixin Qiu; Peng Lin; Michael H Lorenzini; Behnam Badie; Stephen J Forman; Qi Xie
Journal:  Cancer Discov       Date:  2020-12-16       Impact factor: 39.397

6.  Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer.

Authors:  Yi-Na Liu; Han Zhang; Lin Zhang; Ting-Ting Cai; Dai-Jia Huang; Jia He; Huan-He Ni; Fang-Jian Zhou; Xiao-Shi Zhang; Jiang Li
Journal:  Cell Death Dis       Date:  2019-01-18       Impact factor: 8.469

Review 7.  Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers.

Authors:  Ha Thi Thu Do; Chang Hoon Lee; Jungsook Cho
Journal:  Cancers (Basel)       Date:  2020-01-24       Impact factor: 6.639

Review 8.  Function of TREM1 and TREM2 in Liver-Related Diseases.

Authors:  Huifang Sun; Jianguo Feng; Liling Tang
Journal:  Cells       Date:  2020-12-07       Impact factor: 6.600

Review 9.  Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.

Authors:  Zeli Yin; Keqiu Jiang; Rui Li; Chengyong Dong; Liming Wang
Journal:  Mol Cancer       Date:  2018-12-28       Impact factor: 27.401

10.  Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway.

Authors:  Jingyao Lian; Saisai Liu; Ying Yue; Qingshan Yang; Zhen Zhang; Shengli Yang; Yi Zhang
Journal:  Cancer Sci       Date:  2020-11-17       Impact factor: 6.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.